CREDIT SUISSE AG/ - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$4,740,136
-7.5%
80,642
-5.8%
0.01%0.0%
Q4 2023$5,122,281
+54.8%
85,571
-1.7%
0.01%
+66.7%
Q3 2023$3,309,975
-61.3%
87,013
-7.3%
0.00%
-62.5%
Q2 2023$8,552,742
+54.5%
93,883
+11.8%
0.01%
+33.3%
Q1 2023$5,537,210
+39.2%
83,948
+9.2%
0.01%
+50.0%
Q4 2022$3,976,912
-24.2%
76,908
+0.0%
0.00%
-33.3%
Q3 2022$5,250,000
+79.3%
76,870
+18.7%
0.01%
+100.0%
Q2 2022$2,928,000
-18.0%
64,762
-7.8%
0.00%0.0%
Q1 2022$3,570,000
+19.8%
70,266
+11.5%
0.00%
+50.0%
Q4 2021$2,980,000
+52.7%
63,032
+6.5%
0.00%
+100.0%
Q3 2021$1,951,000
-32.5%
59,187
+29.4%
0.00%
-50.0%
Q2 2021$2,890,000
+39.7%
45,728
-5.1%
0.00%
+100.0%
Q1 2021$2,069,000
-60.1%
48,208
-46.8%
0.00%
-66.7%
Q4 2020$5,181,000
+62.9%
90,570
-14.1%
0.00%
+50.0%
Q3 2020$3,181,000
-23.7%
105,422
-17.4%
0.00%
-33.3%
Q2 2020$4,168,000
+185.3%
127,599
+134.1%
0.00%
+200.0%
Q1 2020$1,461,000
-21.0%
54,516
-9.7%
0.00%0.0%
Q4 2019$1,850,000
+49.0%
60,388
+17.2%
0.00%0.0%
Q3 2019$1,242,000
+70.6%
51,540
+79.4%
0.00%0.0%
Q2 2019$728,000
+56.9%
28,725
+20.5%
0.00%
Q1 2019$464,000
+79.8%
23,840
+21.9%
0.00%
Q4 2018$258,000
+7.1%
19,556
+44.1%
0.00%
Q3 2018$241,000
-24.7%
13,569
-6.6%
0.00%
Q2 2018$320,00014,5350.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders